We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Corbus Pharmaceuticals
CRBP
$180M
| $378K | ﹤0.01% |
2,156
+746
| +53% | +$149K |
|
2427
First Bancorp
FNLC
$398M
| $378K | ﹤0.01% |
14,380
+4,368
| +44% | +$121K |
|
|
PETX
2428
DELISTED
Aratana Therapeutics, Inc.
PETX
| $378K | ﹤0.01% |
61,611
+20,326
| +49% | +$124K |
|
|
RARX
2429
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $377K | ﹤0.01% |
20,725
+6,432
| +45% | +$101K |
|
2430
Ribbon Communications
RBBN
$376M
| $375K | ﹤0.01% |
77,742
+23,308
| +43% | +$135K |
|
2431
CryoPort
CYRX
$741M
| $374K | ﹤0.01% |
33,919
+11,321
| +50% | +$123K |
|
2432
Tenable Holdings
TENB
$3.98B
| $374K | ﹤0.01% |
16,876
+7,008
| +71% | +$199K |
|
|
FRBK
2433
DELISTED
Republic First Bancorp Inc
FRBK
| $374K | ﹤0.01% |
62,680
+18,274
| +41% | +$124K |
|
|
TCDA
2434
DELISTED
Tricida, Inc. Common Stock
TCDA
| $371K | ﹤0.01% |
15,717
+6,869
| +78% | +$197K |
|
|
GDEN
2435
DELISTED
Golden Entertainment
GDEN
| $370K | ﹤0.01% |
23,103
+7,606
| +49% | +$138K |
|
2436
Hingham Institution for Saving
HIFS
$658M
| $368K | ﹤0.01% |
1,860
+579
| +45% | +$121K |
|
2437
Lindblad Expeditions
LIND
$2.23B
| $368K | ﹤0.01% |
27,327
+9,175
| +51% | +$122K |
|
|
CIVI
2438
DELISTED
Civitas Solutions, Inc.
CIVI
| $368K | ﹤0.01% |
21,022
+6,701
| +47% | +$100K |
|
2439
VSE Corp
VSEC
$6.33B
| $365K | ﹤0.01% |
12,211
+3,751
| +44% | +$113K |
|
2440
Titan Machinery
TITN
$448M
| $364K | ﹤0.01% |
27,665
+8,322
| +43% | +$124K |
|
2441
Westwood Holdings Group
WHG
$185M
| $364K | ﹤0.01% |
10,718
+3,479
| +48% | +$143K |
|
2442
Primis Financial Corp
FRST
$405M
| $363K | ﹤0.01% |
27,465
+8,180
| +42% | +$123K |
|
2443
V2X
VVX
$2.65B
| $362K | ﹤0.01% |
16,777
+4,837
| +41% | +$124K |
|
|
XXII
2444
22nd Century Group
XXII
$1.49M
| – | – |
0
| – | – |
|
|
AFI
2445
DELISTED
Armstrong Flooring, Inc.
AFI
| $358K | ﹤0.01% |
30,229
+8,834
| +41% | +$136K |
|
2446
Greenlight Captial
GLRE
$511M
| $357K | ﹤0.01% |
41,437
+12,004
| +41% | +$131K |
|
|
FARM
2447
DELISTED
Farmer Brothers
FARM
| $356K | ﹤0.01% |
15,243
+4,392
| +40% | +$106K |
|
2448
Intrepid Potash
IPI
$469M
| $356K | ﹤0.01% |
13,688
+3,957
| +41% | +$136K |
|
2449
KRONOS Worldwide
KRO
$947M
| $356K | ﹤0.01% |
30,913
+9,469
| +44% | +$128K |
|
|
ZAGG
2450
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $355K | ﹤0.01% |
36,327
+11,903
| +49% | +$134K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.